Abstract
With recent advances in our understanding of the continuous pathophysiological changes that begin many years prior to symptom onset, it is now apparent that Alzheimer's disease cannot be adequately described by discrete clinical stages, but should also incorporate the continuum of biological changes that precede and underlie the clinical representation of the disease. By jointly considering longitudinal changes of all available biomarkers and clinical assessments, variation within individuals can be integrated into a single continuous measure of disease progression and used to identify the earliest pathophysiological changes. Disease time, a measure of disease severity, was estimated using a Bayesian latent time joint mixed-effects model applied to an array of imaging, biomarker and neuropsychological data. Trajectories of regional amyloid β and tau PET uptake were estimated as a function of disease time. Regions with early signs of elevated amyloid β uptake were used to form an early, focal composite and compared to a commonly used global composite, in a separate validation sample. Disease time was estimated in 279 participants (183 cognitively unimpaired individuals, 61 mild cognitive impairment and 35 Alzheimer's disease dem...Continue Reading
References
Nov 26, 2004·Clinical Chemistry·Annika OlssonKaj Blennow
Mar 20, 2009·Annals of Neurology·Leslie M ShawUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 1, 2011·Annals of Neurology·Victor L VillemagneChristopher C Rowe
Sep 3, 2011·NeuroImage·Elizabeth C MorminoWilliam J Jagust
Dec 14, 2011·Annals of Neurology·Andrei G VlassenkoJohn C Morris
Feb 15, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Abhinay D JoshiUNKNOWN Florbetapir F 18 Study Investigators
May 26, 2012·Brain : a Journal of Neurology·Nicolas VillainUNKNOWN AIBL Research Group
Oct 31, 2012·Annals of Neurology·Susan M LandauUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 25, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michael C DonohueUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Oct 28, 2015·Annals of Neurology·Keith A JohnsonReisa Sperling
Mar 5, 2016·Neuron·Michael SchöllWilliam J Jagust
Jun 21, 2016·Annals of Neurology·Hanna ChoChul Hyoung Lyoo
Jun 8, 2017·NeuroImage·Anne MaassUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 2, 2017·Nature Communications·Sebastian PalmqvistOskar Hansson
Nov 24, 2017·Statistical Methods in Medical Research·Dan LiUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Feb 9, 2018·Nature·Akinori NakamuraKatsuhiko Yanagisawa
Oct 8, 2018·Neurobiology of Aging·Stephanie A SchultzTammie L S Benzinger
Jan 15, 2019·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Niklas MattssonOskar Hansson
Apr 23, 2019·JAMA Neurology·Niklas MattssonKaj Blennow
Jul 18, 2019·JAMA Neurology·Niklas MattssonOskar Hansson
Citations
Aug 10, 2020·Journal of Neurochemistry·Samantha De La-RocqueGiampietro Schiavo
Sep 17, 2020·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Won-Jin MoonSeol-Heui Han
Aug 3, 2020·Journal of Neural Transmission·Kurt A Jellinger
Nov 18, 2020·Neurology·Michelle E FarrellUNKNOWN Alzheimer's Disease Neuroimaging Initiative and the Harvard Aging Brain Study
Feb 9, 2021·Journal of Alzheimer's Disease : JAD·Enrico PeiraFlavio Nobili
Oct 14, 2020·PLoS Computational Biology·Travis B ThompsonUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Feb 2, 2021·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Miriam Palomar-BonetJose L Cantero
Jan 8, 2021·Neurology·William J JagustUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 19, 2021·NeuroImage. Clinical·Helena M GellersenSaber Sami
Mar 29, 2021·Alzheimer's Research & Therapy·Santiago BullichMercè Boada
Mar 31, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Rachel F Buckley
Apr 25, 2021·Neurobiology of Aging·Priya PaltaJosé A Luchsinger
Apr 21, 2021·Alzheimer's Research & Therapy·Isadora Lopes AlvesJuan Domingo Gispert
May 28, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Antoine LeuzyOskar Hansson
Jun 5, 2021·Brain Communications·Clément Abi NaderUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jun 15, 2021·Frontiers in Aging Neuroscience·Justinas NarbutasFabienne Collette
Jul 24, 2021·JAMA Network Open·Philip S InselR Scott Mackin
Jun 7, 2021·Aging·Wanting LiuUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jul 20, 2021·Journal of Alzheimer's Disease : JAD·Justinas NarbutasFabienne Collette
Aug 5, 2021·Dementia & Neuropsychologia·Claudia Rivera-FernándezMarcio Soto-Añari
Aug 9, 2021·Psychiatry Research. Neuroimaging·Bárbara Duarte-AbrittaSalvador M Guinjoan
Aug 10, 2021·Journal of Alzheimer's Disease : JAD·Laurens Ansem van de MortelUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Sep 5, 2021·Molecular Psychiatry·Rebecca PanitchGyungah R Jun
Aug 13, 2021·Neurology·Seong Ho JeongPhil Hyu Lee
Sep 29, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Dallas P VeitchUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 17, 2021·Brain : a Journal of Neurology·David BerronOskar Hansson